Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A number of cutting edge artificial intelligence (AI) technologies will be tested and scaled in the NHS, as the first winners of the AI in Health and Care Award, sharing approximately £50m. The OxNNet toolkit led by Prof Sally Collins in the Nuffield Department of Women's & Reproductive Health, will receive a share of £50M funding from the NIHR. This exciting project seeks to develop a fully automated ultrasound tool to screen for fetal growth restriction (FGR) in the first trimester.

young woman doctor is viewing an ultrasound result

The NHS is committed to becoming a world leader in the use of artificial intelligence (AI) and machine learning and to harness the benefits on offer from the technology that range from faster and more personalised diagnosis to potential efficiencies in screening services. 

Today’s announcement of the AI in Health and Care Award from the National Institute for Health Research (NIHR) will distribute £140m over three years, and AI tools and products will receive a share of funding totalling over £50m. The funding supports a range of technologies at different stages of development, from concepts to first real-world tests to the scaling of AI products to a number of NHS sites to generate further evidence for potential adoption in the NHS. Each product will undergo robust testing and independent evaluation to ensure they are effective, accurate, safe and value for money.

The full story is available on the Nuffield Department of Women's & Reproductive Health website

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.